{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:11:19Z","timestamp":1784743879645,"version":"3.55.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Multiple myeloma (MM) is characterized by the accumulation of malignant plasma cells preferentially in the bone marrow. Currently, emerging chemotherapy drugs with improved biosafety profiles, such as immunomodulatory agents and protease inhibitors, have been used in clinics to treat MM in both initial therapy or maintenance therapy post autologous hematopoietic stem cell transplantation (ASCT). We previously discovered that caffeic acid phenethyl ester (CAPE), a water-insoluble natural compound, inhibited the growth of MM cells by inducing oxidative stress. As part of our continuous effort to pursue a less toxic yet more effective therapeutic approach for MM, the objective of this study is to investigate the potential of CAPE for <jats:italic>in vivo<\/jats:italic> applications by using magnetic resonance imaging (MRI)-capable superparamagnetic iron oxide nanoparticles (IONP) as carriers. Cyclo (Arg-Gly-Asp-D-Phe-Cys) (RGD) is conjugated to IONP (RGD-IONP\/CAPE) to target the overexpressed \u03b1<jats:sub>v<\/jats:sub>\u03b2<jats:sub>3<\/jats:sub> integrin on MM\u00a0cells for receptor-mediated internalization and intracellular delivery of CAPE. A stable loading of CAPE on IONP can be achieved with a loading efficiency of 48.7% \u00b1 3.3% (wt%). The drug-release studies indicate RGD-IONP\/CAPE is stable at physiological (pH 7.4) and basic pH (pH 9.5) and subject to release of CAPE at acidic pH (pH 5.5) mimicking the tumor and lysosomal condition. RGD-IONP\/CAPE causes cytotoxicity specific to human MM RPMI8226, U266, and NCI-H929 cells, but not to normal peripheral blood mononuclear cells (PBMCs), with IC50s of 7.97 \u00b1 1.39, 16.75 \u00b1 1.62, and 24.38 \u00b1 1.71\u00a0\u03bcM after 72-h treatment, respectively. Apoptosis assays indicate RGD-IONP\/CAPE induces apoptosis of RPMI8226 cells through a caspase-9 mediated intrinsic pathway, the same as applying CAPE alone. The apoptogenic effect of RGD-IONP\/CAPE was also confirmed on the RPMI8226 cells co-cultured with human bone marrow stromal cells HS-5 in a Transwell model to mimic the MM microenvironment in the bone marrow. In conclusion, we demonstrate that water-insoluble CAPE can be loaded to RGD-IONP to greatly improve the biocompatibility and significantly inhibit the growth of MM\u00a0cells <jats:italic>in vitro<\/jats:italic> through the induction of apoptosis. This study paves the way for investigating the MRI-trackable delivery of CAPE for MM treatment in animal models in the future.<\/jats:p>","DOI":"10.3389\/fphar.2024.1325196","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:46:32Z","timestamp":1709729192000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor integrin targeted theranostic iron oxide nanoparticles for delivery of caffeic acid phenethyl ester: preparation, characterization, and anti-myeloma activities"],"prefix":"10.3389","volume":"15","author":[{"given":"Barkley","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuancheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Staskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3906\/sag-1401-127","article-title":"An in vitro and in vivo investigation of the cytotoxic effects of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester and bortezomib in multiple myeloma cells","volume":"45","author":"Altayli","year":"2015","journal-title":"Turk J. Med. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/s0002-9440(10)63293-2","article-title":"Regulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosis","volume":"165","author":"Antonov","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1593\/tlo.08202","article-title":"Caffeic acid phenylethyl ester and MG-132 have apoptotic and antiproliferative effects on leukemic cells but not on normal mononuclear cells","volume":"2","author":"Cavaliere","year":"2009","journal-title":"Transl. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1021\/jf063477o","article-title":"In vitro and in vivo stability of caffeic acid phenethyl ester, a bioactive compound of propolis","volume":"55","author":"Celli","year":"2007","journal-title":"J. Agric. Food Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/02652048.2021.1948623","article-title":"Co-delivery of quercetin and caffeic-acid phenethyl ester by polymeric nanoparticles for improved antitumor efficacy in colon cancer cells","volume":"38","author":"Colpan","year":"2021","journal-title":"J. Microencapsul."},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12885-016-2999-1","article-title":"Molecular chess? Hallmarks of anti-cancer drug resistance","volume":"17","author":"Cree","year":"2017","journal-title":"BMC Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","article-title":"Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications","volume":"138","author":"Dadfar","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0267979","DOI":"10.1371\/journal.pone.0267979","article-title":"Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma","volume":"17","author":"Daniele","year":"2022","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13735","DOI":"10.3390\/ijms232213735","article-title":"Delivery of theranostic nanoparticles to various cancers by means of integrin-binding peptides","volume":"23","author":"Egorova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial","volume":"370","author":"Facon","year":"2007","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.2174\/138955710791384081","article-title":"Bioavailability challenges associated with development of anti-cancer phenolics","volume":"10","author":"Gao","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/cancers13020217","article-title":"The role of tumor microenvironment in multiple myeloma development and progression","volume":"13","author":"Garcia-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3109\/09637486.2011.585963","article-title":"Caffeic acid phenethyl ester (CAPE): correlation of structure and antioxidant properties","volume":"62","author":"Gocer","year":"2011","journal-title":"Int. J. Food Sci. Nutr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1002\/adfm.201504185","article-title":"Magnetic nanoparticle facilitated drug delivery for cancer therapy with targeted and image-guided approaches","volume":"26","author":"Huang","year":"2016","journal-title":"Adv. Funct. Mater"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1021\/am400713j","article-title":"Casein-coated iron oxide nanoparticles for high MRI contrast enhancement and efficient cell targeting","volume":"5","author":"Huang","year":"2013","journal-title":"ACS Appl. Mater Interfaces"},{"key":"B17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin. Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12033-012-9623-7","article-title":"Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer","volume":"55","author":"Khushnud","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02785870","article-title":"Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment","volume":"16","author":"Knudsen","year":"1999","journal-title":"Med. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nri3920","article-title":"Regulation of macrophage development and function in peripheral tissues","volume":"15","author":"Lavin","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jps.24278","article-title":"Preparation of caffeic acid phenethyl ester-incorporated nanoparticles and their biological activity","volume":"104","author":"Lee","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.colsurfb.2016.10.026","article-title":"Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles","volume":"150","author":"Lin","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1039\/C4TB01828A","article-title":"PEG-b-AGE polymer coated magnetic nanoparticle probes with facile functionalization and anti-fouling properties for reducing non-specific uptake and improving biomarker targeting","volume":"3","author":"Li","year":"2015","journal-title":"J. Mater Chem. B"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1021\/acsabm.0c00368","article-title":"Targeted imaging of CD206 expressing tumor-associated M2-like macrophages using mannose-conjugated antibiofouling magnetic iron oxide nanoparticles","volume":"3","author":"Li","year":"2020","journal-title":"ACS Appl. Bio Mater"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e2102816","DOI":"10.1002\/adhm.202102816","article-title":"Targeted delivery of DNA topoisomerase inhibitor SN38 to intracranial tumors of glioblastoma using sub-5 ultrafine iron oxide nanoparticles","volume":"11","author":"Li","year":"2022","journal-title":"Adv. Healthc. Mater"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3390\/cancers13071711","article-title":"RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (Re-)Shape an ever-evolving field","volume":"13","author":"Ludwig","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00210-021-02054-w","article-title":"Recent progresses in the pharmacological activities of caffeic acid phenethyl ester","volume":"394","author":"Lv","year":"2021","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"157496","DOI":"10.1155\/2012\/157496","article-title":"Bone marrow microenvironment in multiple myeloma progression","volume":"2012","author":"Manier","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s10637-018-0701-y","article-title":"Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells","volume":"37","author":"Marin","year":"2019","journal-title":"Invest. New Drugs"},{"key":"B33","doi-asserted-by":"publisher","first-page":"eaau9433","DOI":"10.1126\/sciadv.aau9433","article-title":"Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7","volume":"5","author":"Mccomb","year":"2019","journal-title":"Sci. Adv."},{"key":"B34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"B35","doi-asserted-by":"publisher","first-page":"145342","DOI":"10.1155\/2014\/145342","article-title":"Caffeic acid phenethyl ester and therapeutic potentials","volume":"2014","author":"Murtaza","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1021\/acs.jnatprod.0c00350","article-title":"Antimyeloma potential of caffeic acid phenethyl ester and its analogues through Sp1 mediated downregulation of IKZF1-IRF4-MYC Axis","volume":"83","author":"Murugesan","year":"2020","journal-title":"J. Nat. Prod."},{"key":"B37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biopha.2015.01.007","article-title":"Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein","volume":"70","author":"Nabekura","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"B38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/antiox12010060","article-title":"Caffeic acid phenethyl ester loaded PEG-PLGA nanoparticles enhance wound healing in diabetic rats","volume":"12","author":"Nasrullah","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e00251","DOI":"10.1128\/AAC.00251-20","article-title":"Antibacterial effect of caffeic acid phenethyl ester on cariogenic bacteria and Streptococcus mutans biofilms","volume":"64","author":"Niu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3324\/haematol.2013.090977","article-title":"Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells","volume":"99","author":"Noll","year":"2014","journal-title":"Haematologica"},{"key":"B41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0140-6736(06)68338-4","article-title":"Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial","volume":"367","author":"Palumbo","year":"2006","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.4049\/jimmunol.180.3.1545","article-title":"Bone marrow stroma confers resistance to Apo2 ligand\/TRAIL in multiple myeloma in part by regulating c-FLIP","volume":"180","author":"Perez","year":"2008","journal-title":"J. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"113608","DOI":"10.1016\/j.ab.2020.113608","article-title":"A systematic approach to quantitative Western blot analysis","volume":"593","author":"Pillai-Kastoori","year":"2020","journal-title":"Anal. Biochem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hon.2586","article-title":"Multiple myeloma: every year a new standard?","volume":"37","author":"Rajkumar","year":"2019","journal-title":"Hematol. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am. J. Hematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3390\/ijms21020613","article-title":"Bone marrow stromal cells-induced drug resistance in multiple myeloma","volume":"21","author":"Ria","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B47","first-page":"836","article-title":"Alpha(v)beta(3) integrin engagement enhances cell invasiveness in human multiple myeloma","volume":"87","author":"Ria","year":"2002","journal-title":"Haematologica"},{"key":"B48","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1097\/CAD.0000000000000941","article-title":"Growth inhibition and apoptosis of human multiple myeloma cells induced by 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid derivatives","volume":"31","author":"Rogers","year":"2020","journal-title":"Anticancer Drugs"},{"key":"B49","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"S721","DOI":"10.1177\/09603271211054436","article-title":"Investigation of the anti-inflammatory effects of caffeic acid phenethyl ester in a model of lambda-Carrageenan-induced paw edema in rats","volume":"40","author":"Semis","year":"2021","journal-title":"Hum. Exp. Toxicol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/antiox11081536","article-title":"A nano-liposomal formulation of caffeic acid phenethyl ester modulates Nrf2 and NF-\u03ba\u03b2 signaling and alleviates experimentally induced acute pancreatitis in a rat model","volume":"11","author":"Shahin","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/ijms19071979","article-title":"Gold nanoparticles in diagnostics and therapeutics for human cancer","volume":"19","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"12590","DOI":"10.3390\/ijms241612590","article-title":"Cytotoxic and apoptotic effects of pinostilbene and bortezomib combination treatment on human multiple myeloma cells","volume":"24","author":"Staskiewicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"118975","DOI":"10.1016\/j.lfs.2020.118975","article-title":"Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases","volume":"267","author":"Thapa","year":"2021","journal-title":"Life Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1080\/10408398.2013.821967","article-title":"Caffeic acid phenethyl ester: a review of its antioxidant activity, protective effects against ischemia-reperfusion injury and drug adverse reactions","volume":"56","author":"Tolba","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"B57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.20517\/cdr.2022.32","article-title":"Cancer drug resistance in multiple myeloma","volume":"5","author":"Uckun","year":"2022","journal-title":"Cancer Drug Resist"},{"key":"B58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/17425247.2019.1554647","article-title":"Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics","volume":"16","author":"Vangijzegem","year":"2019","journal-title":"Expert Opin. Drug Deliv."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1039\/c9ra09441e","article-title":"A novel nanoparticle loaded with methyl caffeate and caffeic acid phenethyl ester against Ralstonia solanacearum-a plant pathogenic bacteria","volume":"10","author":"Wang","year":"","journal-title":"RSC Adv."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.3390\/cancers12092370","article-title":"Novel caffeic acid phenethyl ester-mortalin antibody nanoparticles offer enhanced selective cytotoxicity to cancer cells","volume":"12","author":"Wang","year":"","journal-title":"Cancers (Basel)"},{"key":"B61","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/bmc.737","article-title":"Stability of caffeic acid phenethyl ester and its fluorinated derivative in rat plasma","volume":"21","author":"Wang","year":"2007","journal-title":"Biomed. Chromatogr."},{"key":"B62","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/bdd.657","article-title":"Pharmacokinetics of caffeic acid phenethyl ester and its catechol-ring fluorinated derivative following intravenous administration to rats","volume":"30","author":"Wang","year":"2009","journal-title":"Biopharm. Drug Dispos."},{"key":"B63","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.2147\/IJN.S92162","article-title":"Natural product-based nanomedicine: recent advances and issues","volume":"10","author":"Watkins","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e2100884","DOI":"10.1002\/adhm.202100884","article-title":"A 3D-bioprinted multiple myeloma model","volume":"11","author":"Wu","year":"2022","journal-title":"Adv. Healthc. Mater"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1644","DOI":"10.1002\/wnan.1644","article-title":"Going even smaller: engineering sub-5 nm nanoparticles for improved delivery, biocompatibility, and functionality","volume":"12","author":"Xie","year":"2020","journal-title":"Wiley Interdiscip. Rev. Nanomed Nanobiotechnol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10637-022-01231-9","article-title":"Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer","volume":"40","author":"Xue","year":"2022","journal-title":"Invest. New Drugs"},{"key":"B67","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.freeradbiomed.2020.09.013","article-title":"Altered redox regulation and S-glutathionylation of BiP contribute to bortezomib resistance in multiple myeloma","volume":"160","author":"Zhang","year":"2020","journal-title":"Free Radic. Biol. Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1325196\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T12:46:36Z","timestamp":1709729196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1325196\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":67,"alternative-id":["10.3389\/fphar.2024.1325196"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1325196","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1325196"}}